Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Haisco

Biotech & Life Sciences · Lhoka, China · Founded 2000 · IPO 2012 Unicorn

Diversified pharmaceutical group focused on research, development, manufacturing and sales of chemical and specialty drugs

Valuation
$9.05B
Market cap · May/2026
Revenue
$603M
Latest reported FY
EBITDA
$190M
Latest reported FY

Investors

2 investors on Haisco's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 2 investors entered at this stage
JP Morgan
Fullgoal Fund

Global footprint

Where Haisco has talent and traffic

Workforce by country
3 countries with
team presence
🇨🇳 China66.7%
🇮🇹 Italy27.8%
🇭🇰 Hong Kong25%
3 countries shown

Patent intelligence

$99M patent portfolio · 293 active families

Estimated portfolio value
$99M
1.1% of market cap · 2.8× smaller than top peer Ascendis Pharma ($275M)
293 active patent families
Where Haisco innovates Medicinal chemistryPharmaceutical SubstancesPharmaceutical medicinePharmaceutical drugDisease

Where Haisco concentrates vs peers

Each axis is a top-10 topic across Haisco and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Haisco's 6 investments and acquisitions.

Every disclosed deal where Haisco appeared as a backer or acquirer, 2015–2019. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

6 deals across Haisco's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Haisco deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Haisco's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        6 of 6 deals

        Market sentiment

        What the market is saying about Haisco

        An AI-synthesized read of the highest-engagement posts about Haisco on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Haisco on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.